4//SEC Filing
Halladay Benjamin 4
Accession 0001628280-24-051875
CIK 0001434868other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:14 PM ET
Size
18.0 KB
Accession
0001628280-24-051875
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-12-17$2.42/sh−3,245$7,866→ 240,691 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001953943
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:14 PM ET
- Size
- 18.0 KB